News

2022

Select year
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015

PHC Holdings Corporation

Group Companies

Dec.1News: Announcement of New Assignment of Corporate Officer at PHC Holdings Corporation Effective January 1, 2023
Nov.16News: PHC Group Releases Newly Revised Mid-Term Plan, the "Value Creation Plan," Outlining Changes for FY2025 to Accelerate Growth by Advancing Value-Based Healthcare
Nov.16IR: Notice of establishment of a new company and the integration (company split/absorption-type merger) of Medical Information Systems (Medicom) Business Unit, PHC Corporation and PHC Medicom Corporation which are wholly-owned subsidiaries of PHC Holdings Corporation
Sep.1News: Announcement of Changes in Corporate Officer Area of Responsibility at PHC Holdings Corporation Effective September 1, 2022
Aug.12News: Announcement of Resignation of Corporate Officer at PHC Holdings Corporation and New Assignment at PHC Group Subsidiary
Jun.29News: Announcement of Changes in Board Members and Audit and Supervisory Board Member at PHC Holdings Corporation Effective June 29 and July 1, 2022
Jun.13News: Announcement of Changes in Corporate Officers at PHC Holdings Corporation Effective June 13 and July 1, 2022
Jun.13News: Announcement of Resignation of a Corporate Officer at PHC Holdings Corporation Effective June 1, 2022
May.25IR: Notice regarding the Early Retirement Program at PHC Holdings Corporation and the consolidated subsidiaries
May.25News: Announcement of Changes to Board of Directors at PHC Holdings Corporation Effective June 29 and July 1
May.12IR: PHC Holdings Corporation Announces FY21 Full-Year Results and FY22 Forecast
Apr.28News: PHC Holdings Corporation Appoints Shoji Miyazaki as Chief Executive Officer
Apr.22News: Resignation of Independent External Director of PHC Holdings Corporation
Apr.4News: Resignation of Independent External Director of PHC Holdings Corporation

Jan.19News: Changes in Corporate Officer Areas of Responsibility at PHC Holdings Corporation Effective January 19, 2022

Nov.3AscensiaProducts: Senseonics and Ascensia Announce a Collaboration with the Nurse Practitioner Group Designed to Expand Patient Access by Providing In-Office and At-Home Insertion Options for Eversense^® E3 Continuous Glucose Monitoring System (CGM)
Nov.2AscensiaProducts: Ascensia Launches The GlucoContro.Online Diabetes Management and Analytics Platform in The U.S.
Oct.10AscensiaProducts: Ascensia Diabetes Care Completes Initial European Launch of The Next-Generation Eversense E3 Continuous Glucose Monitoring System
Sep.27AscensiaCorporate: Ascensia Diabetes Care Relaunches Successful ‘This is Diabetes’ Competition in Support of IDF’s World Diabetes Day
Sep.12MedicomProducts: Launch of Pilot Program Targeting Residents in Condominiums for an Online Medical Check-Up Program - Using Virtual Care Device Teladoc HEALTH and Activity Tracker MOTHER Bracelet
Sep.5EprediaCorporate: Epredia Expands Anatomical Pathology Business in Europe with Acquisition of Microm Microtech France and Laurypath
Aug.30EprediaProducts: Epredia Launches Laser Cassette Printers Designed to Improve Sample Tracking and Laboratory Efficiency
Aug.8PHC IVDProducts: PHC IVD and JCR Announces Upgraded Medication Management App Melon Nikki™ for Pediatric Patients Undergoing Growth Hormone Therapy
Jul.26PHCbiProducts: PHCbi Develops First Prototype for Live Cell Metabolic Analysis, Paving the Way for Advances in Cell Therapy and Gene Therapy
Jun.27PHCCorporate: Announcement of Changes in Board Members at PHC Corporation Effective June 27, 2022
Jun.16AscensiaProducts: Ascensia Diabetes Care Announces European Approval of the Next-Generation Eversense E3 Continuous Glucose Monitoring System
May.25PHCCorporate: Announcement of New Appointment of a Director at PHC Corporation Effective on June 27, 2022
May.2AscensiaProducts: Ascensia Diabetes Care Presents New Research Showing that People Using the CONTOUR® Blood Glucose Monitoring System and App Experience Fewer Out-of-Target Blood Glucose levels
Apr.18PHC IVDProducts: PHC Receives First EU-MDR Certification, Delivers Motorized Drug Injection Device Enabling More Efficient Patient-Friendly Treatment of Arthritis and Other Inflammatory Conditions
Apr.4AscensiaProducts: Ascensia Diabetes Care Launches the 6 Month Eversense® E3 Continuous Glucose Monitoring System in the U.S. with the New Eversense Pass Savings Program
Mar.1AscensiaProducts: Ascensia Diabetes Care Launches the Eversense® Now Remote Monitoring App for Android Users in Europe
Feb.14AscensiaProducts: Ascensia Diabetes Care Announces FDA Approval of the Eversense E3 Continuous Glucose Monitoring System for Use for Up to 6 Months
Feb.14AscensiaCorporate: Ascensia Diabetes Care Proudly Supports Spare a Rose Campaign for Fifth Consecutive Year

PHC Holdings Corporation

About Us

Group Companies

Products & Services

CSR

CORPORATE INTEGRITY

PEOPLE INSIGHTS

ENVIRONMENTAL SUSTAINABILITY

SOCIAL RESPONSIBILITY

Investor Relations

MANAGEMENT

IR LIBRARY

STOCK INFORMATION

2022